Mycophenolic acid inhibits mesangial cell activation through p38 MAPK inhibition

Life Sciences

Volumn 79, Issue 16, 2006, Pages 1561-1567

  Ha, Hunjoo ^a   Kim, Myoung Soo ^b,c   Park, Jehyun ^b   Huh, Joo Young ^a   Huh, Kyu Ha ^b   Ahn, Hyung Joon ^c   Kim, Yu Seun ^b,c  

^a Ewha Womans University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Extracellular matrix; Mesangial cell; Mycophenolic acid; p38 mitogen activated protein kinase; Proliferation

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYCOPHENOLIC ACID; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; KIDNEY TRANSPLANTATION; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FIBRONECTINS; GUANOSINE; MESANGIAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYCOPHENOLIC ACID; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET-DERIVED GROWTH FACTOR; RATS; THYMIDINE;

EID: 33748067423     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.05.001     Document Type: Article

References (46)

1. Allison A.C., and Eugui E.M. Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs. Transplantation Proceedings 25 Suppl.2 (1993) 8-18
2. Allison A.C., and Eugui E.M. Mycophenolate mofetil and its mechanism of action. Immunopharmacology 47 2-3 (2000) 85-118
3. Bertalanffy P., Dubsky P., Wolner E., and Weigel G. Alterations of endothelial nucleotide levels by mycophenolic acid result in changes of membrane glycosylation and E-selectin expression. Clinical Chemistry and Laboratory Medicine 37 3 (1999) 259-264
4. Bottinger E.P., and Bitzer M. TGF-β signaling in renal disease. Journal of the American Society of Nephrology 13 10 (2002) 2600-2610
5. Briggs W.A., Choi M.J., and Scheel P.J. Successful mycophenolate mofetil treatment of glomerular disease. American Journal of Kidney Diseases 31 2 (1998) 213-217
6. Cobb M.H. MAP kinase pathways. Progressive Biophysical Molecular Biology 71 3-4 (1999) 479-500
7. Colvin R.B. Chronic allograft nephropathy. New England Journal of Medicine 349 24 (2003) 2288-2290
8. Contreras G., Pardo V., Leclercq B., Lenz O., Tozman E., O'Nan P., and Roth D. Sequential therapies for proliferative lupus nephritis. New England Journal of Medicine 350 10 (2004) 971-980
9. Dubus I., Vendrely B., Christophe I., Labouyrie J.P., Delmas Y., Bonnet J., and Combe C. Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney International 62 3 (2002) 857-867
10. Dubus I., L'Azou B., Gordien M., Delmas Y., Labouyrie J.P., Bonnet J., and Combe C. Cytoskeletal reorganization by mycophenolic acid alters mesangial cell migration and contractility. Hypertension 42 5 (2003) 956-961
11. Floege J., and Johnson R.J. Multiple roles for platelet-derived growth factor in renal disease. Mineral and Electrolyte Metabolism 21 4-5 (1995) 271-282
12. Floege J., Burns M.W., Alpers C.E., Yoshimura A., Pritzl P., Gordon K., Seifert R.A., Bowen-Pope D.F., Couser W.G., and Johnson R.J. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney International 41 2 (1992) 297-309
13. Floege J., Eng E., Young B.A., and Johnson R.J. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney International. Supplement 39 (1993) S47-S54
14. Gu J.J., Gathy K., Santiago L., Chen E., Huang M., Graves L.M., and Mitchell B.S. Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. Blood 101 12 (2003) 4958-4965
15. Ha H., Yu M.R., Choi Y.J., Kitamura M., and Lee H.B. Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression in mesangial cells. Journal of the American Society of Nephrology 13 4 (2002) 894-902
16. Hauser I.A., Renders L., Radeke H.H., Sterzel R.B., and Goppelt-Struebe M. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrology Dialysis and Transplantation 14 1 (1999) 58-63
17. Hayama M., Inoue R., Akiba S., and Sato T. Inhibitory effect of cepharanthine on fibronectin production in growth factor-stimulated rat mesangial cells. European Journal of Pharmacology 390 1-2 (2000) 37-42
18. Häyry P., Isoniemi H., Yilmaz S., Mennander A., Lemstrom K., Raisanen-Sokolowski A., Koskinen P., Ustinov J., Lautenschlager I., Taskinen E., et al. Chronic allograft rejection. Immunology Reviews 134 (1993) 33-81
19. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 79 4 (1999) 1283-1316
20. Iida H., Seifert R., Alpers C.E., Gronwald R.G., Phillips P.E., Pritzl P., Gordon K., Gown A.M., Ross R., Bowen-Pope D.F., and Johnson R.J. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferation nephritis in the rat. Proceedings of the National Academy of Sciences of the United States of America 88 15 (1991) 6560-6564
21. Johnson R.J., Floege J., Yoshimura A., Iida H., Couser W.G., and Alpers C.E. The activated mesangial cell: a glomerular "myofibroblast"?. Journal of the American Society of Nephrology 2 Suppl. 10 (1992) S190-S197
22. Johnson R., Iida H., Yoshimura A., Floege J., and Bowen-Pope D.F. Platelet-derived growth factor: a potentially important cytokine in glomerular disease. Kidney International 41 3 (1992) 590-594
23. Johnson R.J., Raines E.W., Floege J., Yoshimura A., Pritzl P., Alpers C., and Ross R. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. Journal of Experimental Medicine 175 5 (1992) 1413-1416
24. Kashgarian M., and Sterzel R.B. The pathology of the mesangium. Kidney International 41 3 (1992) 524-529
25. Kawano H., Kim S., Ohta K., Nakao T., Miyazaki H., Nakatani T., and Iwao H. Differential contribution of three mitogen-activated protein kinases to PDGF-induced mesangial cell proliferation and gene expression. Journal of the American Society of Nephrology 14 3 (2003) 584-592
26. Keunecke C., Rothenpieler U., Zanker B., Schneeberger H., Illner W.D., Theodorakis J., Stangl M., and Land W. Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients. Transplantation Proceedings 32 Suppl. 1A (2000) 6S-8S
27. Kimoto K., Nakatsuka K., Matsuo N., and Yoshioka H. p38 MAPK mediates the expression of type I collagen induced by TGF-(2 in human retinal pigment epithelial cells ARPE-19. Investigative Ophthalmology and Visual Science 45 7 (2004) 2431-2437
28. Ludewig D., Kosmehl H., Sommer M., Bohmer F.D., and Stein G. PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction. Cell and Tissue Research 299 1 (2000) 97-103
29. Mohacsi P.J., Tuller D., Hulliger B., and Wijngaard P.L. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. Journal of Heart and Lung Transplantation 16 5 (1997) 484-492
30. Nicholl S.M., Roztocil E., and Davies M.G. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Journal of Vascular Surgery 41 4 (2005) 672-681
31. Oh J.H., Ha H., Yu M.R., and Lee H.B. Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney International 54 6 (1998) 1872-1878
32. Ojo A.O., Meier-Kriesche H.U., Hanson J.A., Leichtman A.B., Cibrik D., Magee J.C., Wolfe R.A., Agodoa L.Y., and Kaplan B. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 69 11 (2000) 2405-2409
33. Olah E., Kote Z., Natsumeda Y., Yamaji Y., Jarai G., Lapis E., Financsek I., and Weber G. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochemistry Biophysics 11 2 (1990) 107-117
34. Ostendorf T., Kunter U., van Roeyen C., Dooley S., Janjic N., Ruckman J., Eitner F., and Floege J. The effect of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of transforming growth factor-β system. Journal of the American Society of Nephrology 13 3 (2002) 658-667
35. Papakrivopoulou J., Lindahl G.E., Bishop J.E., and Laurent G.J. Different roles of extracellular signal-regulated kinase 1/2 and p38 MAPK in mechanical load-induced procollagen α1(I) gene expression in cardiac fibroblasts. Cardiovascular Research 61 4 (2004) 736-744
36. Park J., Ha H., Seo J., Kim M.S., Kim H.J., Huh K.H., Park K., and Kim Y.S. Mycophenolic acid inhibits platelet-derived growth factor-induced reactive oxygen species and mitogen-activated protein kinase activation in rat vascular smooth muscle cells. American Journal of Transplantation 4 12 (2004) 1982-1990
37. Rhyu D.Y., Yang Y., Ha H., Lee G.T., Song J.S., Uh S.T., and Lee H.B. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Journal of the American Society of Nephrology 16 3 (2005) 667-675
38. Savikko J., Kallio E.A., Taskinen E., and von Willebrand E. The effect of acute rejection and cyclosporine A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft failure. Transplantation 73 4 (2002) 506-511
39. Seger R., and Krebs E.G. The MAPK signaling cascade. FASEB Journal 9 9 (1995) 726-735
40. Shimizu A., Yamada K., Sachs D.H., and Colvin R.B. Mechanisms of chronic allograft rejection. II. Progressive allograft glomerulopathy in miniature swine. Laboratory Investigation 82 6 (2002) 673-686
41. Vallee S., Fouchier F., Braguer D., Marvaldi J., and Champion S. Ribavirin-induced resistance to heat shock, inhibition of Ras-Raf1 pathway and arrest in G1. European Journal of Pharmacology 404 1-2 (2000) 49-62
42. Waller J.R., and Nicholson M.L. Molecular mechanisms of renal allograft fibrosis. British Journal of Surgery 88 11 (2001) 1429-1441
43. Yamabe H., Osawa H., Kaizuka M., Tsunoda S., Shirato K., Tateyama F., and Okumura K. Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-beta-dependent mechanism. Nephrology Dialysis Transplantation 15 6 (2000) 872-876
44. Yang B., Cao D.J., Sainz I., Colman R.W., and Guo Y.L. Different roles of ERK and p38 MAPK during tube formation from endothelial cells cultured in 3-dimensional collagen matrices. Journal of Cellular Physiology 200 3 (2004) 360-369
45. Zhan Y., Kim S., Izumi Y., Izumiya Y., Nakao T., Miyazaki H., and Iwao H. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Arteriosclererosis, Thrombosis, and Vascular Biology 23 5 (2003) 795-801
46. Ziswiler R., Steinmann-Niggli K., Kappeler A., Daniel C., and Marti H.-P. Mycophenolic acid: A new approach to the therapy of experimental mesangial proliferative glomerulonephritis. Journal of the American Society of Nephrology 9 11 (1998) 2055-2066